COVID-19 – un premier donneur de plasma de convalescents
April 29, 2020 16:30 ET
|
Société canadienne du sang
VANCOUVER, Colombie-Britannique, 29 avr. 2020 (GLOBE NEWSWIRE) -- La Société canadienne du sang est fière de participer à CONCOR, un essai clinique national visant à déterminer si le plasma de...
Bizagi Launches CoronaPass to Support COVID-19 Anti-Body Testing Certification
April 15, 2020 08:00 ET
|
Bizagi
NEW YORK, April 15, 2020 (GLOBE NEWSWIRE) -- CoronaPass™, a digital solution launched today to help protect the lives and livelihoods of communities, offers governments, healthcare organizations and...
Bizagi Launches CoronaPass to Support COVID-19 Anti-Body Testing Certification
April 15, 2020 08:00 ET
|
Bizagi
NEW YORK, April 15, 2020 (GLOBE NEWSWIRE) -- CoronaPass™, a digital solution launched today to help protect the lives and livelihoods of communities, offers governments, healthcare organizations and...
SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19
March 23, 2020 09:00 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO and BOSTON, March 23, 2020 (GLOBE NEWSWIRE) -- In response to the government call for rapidly deployable countermeasures, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) and...
SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)
March 20, 2020 07:00 ET
|
Sorrento Therapeutics, Inc.
COVIDTRAPTM is a proprietary ACE2-Fc protein that binds to the S1 domain of the spike protein of the SARS-CoV-2 virus;COVIDTRAP is designed to block the SARS-CoV-2 virus from binding and infecting...
Fluidigm Expands Maxpar Antibody Portfolio for High-Multiplex Tissue Imaging
December 10, 2019 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced the availability of...
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
April 15, 2019 09:00 ET
|
BioPorto A/S
Company Plans to Bring Novel Kidney Diagnostic to US Market Hellerup, Denmark, April 15, 2019 (GLOBE NEWSWIRE) -- Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the appointment of Amy...
ABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel Products
February 25, 2019 08:45 ET
|
ABclonal Technology
BOSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- ABclonal Technology, a new and growing provider of biology research reagents and services, and BenchSci, a life science machine learning company backed by...
テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
November 28, 2018 18:17 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリア メルボルン、CEO：Dr. Christian...
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
November 28, 2018 18:17 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...